Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6251368 | GLAXO GRP LTD | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
Dec, 2012
(11 years ago) | |
US6251368 (Pediatric) | GLAXO GRP LTD | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
Jun, 2013
(10 years ago) | |
US6596260 | GLAXO GRP LTD | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Aug, 2014
(9 years ago) | |
US5658549 | GLAXO GRP LTD | Aerosol formulations containing propellant 134a and fluticasone propionate |
Aug, 2014
(9 years ago) | |
US5674472 | GLAXO GRP LTD | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
Oct, 2014
(9 years ago) | |
US6596260 (Pediatric) | GLAXO GRP LTD | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Feb, 2015
(9 years ago) | |
US5658549 (Pediatric) | GLAXO GRP LTD | Aerosol formulations containing propellant 134a and fluticasone propionate |
Feb, 2015
(9 years ago) | |
US5674472 (Pediatric) | GLAXO GRP LTD | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
Apr, 2015
(9 years ago) | |
US6966467 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
US6510969 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
US6170717 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
US6315173 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
US7143908 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
US6938796 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
US6161724 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
US6997349 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
US6435372 | GLAXO GRP LTD | Delivery system for a medicament and method for the assembly thereof |
Jan, 2018
(6 years ago) | |
US7107986 | GLAXO GRP LTD | Dispenser with doses' counter |
Jun, 2018
(5 years ago) | |
US6431168 | GLAXO GRP LTD | Dispenser with doses′ counter |
Jun, 2018
(5 years ago) | |
US6966467 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
US6315173 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
US6170717 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
US6510969 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
US6435372 (Pediatric) | GLAXO GRP LTD | Delivery system for a medicament and method for the assembly thereof |
Jul, 2018
(5 years ago) | |
US7143908 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
US6161724 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
US6997349 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
US6938796 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
US7350676 | GLAXO GRP LTD | Valve for aerosol container |
Aug, 2018
(5 years ago) | |
US7107986 (Pediatric) | GLAXO GRP LTD | Dispenser with doses' counter |
Dec, 2018
(5 years ago) | |
US6431168 (Pediatric) | GLAXO GRP LTD | Dispenser with doses′ counter |
Dec, 2018
(5 years ago) | |
US7350676 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Feb, 2019
(5 years ago) | |
US9861771 | GLAXO GRP LTD | Device housing for an aerosol container |
Oct, 2020
(3 years ago) | |
US6743413 | GLAXO GRP LTD | Suspension aerosol formulations |
Jun, 2021
(2 years ago) | |
US6743413 (Pediatric) | GLAXO GRP LTD | Suspension aerosol formulations |
Dec, 2021
(2 years ago) | |
US7832351 | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Jun, 2023
(10 months ago) | |
US7832351 (Pediatric) | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Dec, 2023
(4 months ago) | |
US7500444 | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Feb, 2026
(1 year, 10 months from now) | |
US7500444 (Pediatric) | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Aug, 2026
(2 years from now) |
Advair Hfa is owned by Glaxo Grp Ltd.
Advair Hfa contains Fluticasone Propionate; Salmeterol Xinafoate.
Advair Hfa has a total of 39 drug patents out of which 37 drug patents have expired.
Expired drug patents of Advair Hfa are:
Advair Hfa was authorised for market use on 08 June, 2006.
Advair Hfa is available in aerosol, metered;inhalation dosage forms.
Advair Hfa can be used as treatment of asthma in patients aged 12 years and older, indicated for the long-term, twice-daily maintenance treatment of asthma in patients 12 years of age or older.
The generics of Advair Hfa are possible to be released after 26 August, 2026.
Drugs and Companies using FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE ingredient
Market Authorisation Date: 08 June, 2006
Treatment: Indicated for the long-term, twice-daily maintenance treatment of asthma in patients 12 years of age or older; Treatment of asthma in patients aged 12 years and older
Dosage: AEROSOL, METERED;INHALATION